EXCEPTIONAL LONG-TERM SURVIVAL OF AN ELDERLY PATIENT WITH METASTATIC SMALL CELL NEUROENDOCRINE CARCINOMA OF THE CERVIX – A CASE REPORT

Received 2022-09-18; Accepted 2023-05-15; Published 2023-08-23

Authors

  • Yun Yi Ho Clinical Oncology Unit, Faculty of Medicine, University Malaya, 50603 Kuala Lumpur, Malaysia.
  • Nia Wei Yuen Hiew Clinical Oncology Unit, Faculty of Medicine, University Malaya, 50603 Kuala Lumpur, Malaysia.
  • Gwo Fuang Ho Clinical Oncology Unit, Faculty of Medicine, University Malaya, 50603 Kuala Lumpur, Malaysia.

DOI:

https://doi.org/10.22452/jummec.vol26no2.13

Abstract

Small cell neuroendocrine cervical carcinoma (SCCC) is known for its aggressive nature and poor prognosis. There are no standard treatments so small cell lung cancer treatments are often referenced due to their similar morphology. Typical treatment options include a combination of external beam radiotherapy and brachytherapy for localised disease and palliative chemotherapy for advanced disease. The 5-year survival rate for patients presenting with advanced disease is dismal, around 0–14%. Here, we report a case of a 75-year-old woman who was diagnosed with small cell neuroendocrine cervical carcinoma (SCCC) in 2015. She presented with locally advanced SCCC with
vaginal involvement, as well as solitary lung and peripancreatic metastases. She was treated with a combination of chemotherapy, chemoradiation and stereotactic radiotherapy, followed by maintenance etoposide, and achieved a very long-term survival. The patient continues to survive today.

Downloads

Download data is not yet available.

Downloads

Published

2023-08-23

Issue

Section

Research article

Most read articles by the same author(s)